10
Participants
Start Date
September 1, 2017
Primary Completion Date
March 25, 2019
Study Completion Date
March 25, 2019
Optune
"Optune is a wearable and portable, FDA-approved device that has been shown in clinical trials to safely deliver continuous therapy to the area of your brain where your GBM (Glioblastoma) tumor is located.~TMZ (Temozolomide) is an oral chemotherapy drug. It is an alkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme."
Baylor Scott and White Medical Center, Temple
Lead Sponsor
Baylor Research Institute
OTHER